Clinical Trial Update: Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)

View source ↗

Summary

This clinical-trial update reports the completion of a study evaluating disease severity in adults with Neurofibromatosis Type 1 and Legius Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Legius Syndrome
• Neurofibromatosis Type

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis Type 1, Legius Syndrome | Status: COMPLETED